Ratios Reveal: Breaking Down Jasper Therapeutics Inc (JSPR)’s Financial Health

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

Jasper Therapeutics Inc (NASDAQ: JSPR) closed the day trading at $6.77 down -0.73% from the previous closing price of $6.82. In other words, the price has decreased by -$0.73 from its previous closing price. On the day, 0.34 million shares were traded. JSPR stock price reached its highest trading level at $7.19 during the session, while it also had its lowest trading level at $6.605.

Ratios:

For a better understanding of JSPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.31 and its Current Ratio is at 4.31. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on February 13, 2025, initiated with a Buy rating and assigned the stock a target price of $38.

On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $63.

On September 09, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $70.JMP Securities initiated its Mkt Outperform rating on September 09, 2024, with a $70 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’24 when Mahal Jeetinder Singh sold 900 shares for $22.11 per share. The transaction valued at 19,899 led to the insider holds 25,009 shares of the business.

Jeetinder Singh Mahal bought 900 shares of JSPR for $20,223 on Dec 12 ’24. On Sep 12 ’24, another insider, Mahal Jeetinder Singh, who serves as the Chief Operating Officer of the company, sold 900 shares for $21.23 each. As a result, the insider received 19,104 and left with 25,009 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JSPR now has a Market Capitalization of 101699616 and an Enterprise Value of 37163776.

Stock Price History:

The Beta on a monthly basis for JSPR is 2.73, which has changed by -0.679754 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, JSPR has reached a high of $26.05, while it has fallen to a 52-week low of $3.13. The 50-Day Moving Average of the stock is 27.86%, while the 200-Day Moving Average is calculated to be -40.89%.

Shares Statistics:

Over the past 3-months, JSPR traded about 250.50K shares per day on average, while over the past 10 days, JSPR traded about 556220 shares per day. A total of 15.02M shares are outstanding, with a floating share count of 12.59M. Insiders hold about 16.21% of the company’s shares, while institutions hold 73.92% stake in the company. Shares short for JSPR as of 1749772800 were 1542695 with a Short Ratio of 6.16, compared to 1747267200 on 1744284. Therefore, it implies a Short% of Shares Outstanding of 1542695 and a Short% of Float of 10.3999995.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.